Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma

OSS, The Netherlands, October 30 /PRNewswire/ -- Organon, the human healthcare business unit of Akzo Nobel, today announced that it has signed an exclusive, worldwide license agreement with Endotis Pharma concerning the development and commercialization of several antithrombotic compounds. End...

Karnataka Pharmacy Gets Licence to Produce Medicines from White Arecanut

The Arecanut Research and Development Foundation at Mangalore in the southern Indian state of Karnataka has been granted licence for commercial manufacture of two Ayurvedic medicines using white arecanut.// The areca nut, a favourite of the Indian betel chewers, has been known to have some medic...

A success for the Indian pharmacy: gets licence to manufacture Tamiflu

The anti flu treatment medicine acclaimed the world over Tamiflu now will be made in India. The licence has been given by Swiss firm Roche to make a generic version of its anti-flu treatment Tamiflu for India and other developing // countries. The company is Hetero Drugs. The drug is widely se...

Hike in drug licence fee could hit several SSI units in TN

The recent hike in the drug manufacturing licence fee and product inspection fee could badly hit several small scale drug units in Tamil Nadu. According to industry sources here, the steep hike in the licensing fees has come at a time when the industry in the state is reeling under tight market con...

Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent Office

...uired and where appropriate will build an in-house sales and marketing capability to direct distribution of its products. Enigma has an exclusive licence from the Defence Science and Technology Laboratory to a portfolio of patents, which represent over 15 years of UK Ministry of Defence funded research ...

Starpharma and Elanco Sign Agreement

...in the USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents through licence arrangements with partners including Siemens and Merck KgA. For further information: Media Buchan Consulting Rebecca W...

PeopleStreme Releases RapidEcho Online Tool for Employee Personal Development

... More information More information is available at http://www.rapidecho.com . Rapid Echo is available as a web subscription product, corporate licence or as a product integrated with Performance and Talent Management from PeopleStreme. About PeopleStreme PeopleStreme is a global leader in inn...

Shadow Technology Offer "Recession Buster Discount" on Call-Shadow IP Call Management Software

...09, we are offering a 25% discount on the software licence and support. A 5 user licence with 12 months support will be reduced from $2,370 to $1,777.50 - a saving of $592.50 and a 10 user licence from $4,740 to $3,555, a saving of $1,185" he...

Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics

...r of the Arana Group; or (cc) takes a licence, offers to take a licence or agrees to take a licence of intellectual property of any person other than a member of the Arana Gro...

Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)

...dent & CEO: Haruo Naito), and Bial-Portela & CA, S.A., (S. Mamede do Coronado, Portugal, CEO Dr Luis Portela) today announced the signing of a licence and co-promotion agreement in which Eisai receives a sole license to market, promote and distribute the novel once daily anti-epileptic Zebinix(R) (es...

licence in Medical Technology

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

...high as we anticipate confirmation of such benefit in a large target patient population." Notes for Editors: About the NVA237 and QVA149 licence agreement with Novartis Sosei and Vectura Group plc concluded a global development and commercialisation agreement with Novartis in April 2005 ...

AFFiRiS Begins Development of a Parkinson's Vaccine

...-amyloid, which is said to be responsible for Alzheimer's. Both Alzheimer's vaccines are currently being trialled on Alzheimer patients. In October, a licence option agreement worth up to EUR 430 million was concluded with GlaxoSmithKline Biologicals for their further clinical development market launch and s...

New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer

...he above mentioned studies and data represent the latest results of clinical research for each treatment and are not necessarily part of the indicated licence in each country. For detailed label information, visit the website of your health authority or the EMEA website http://www.emea.europa.eu/ N...

Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology

...ity of Cambridge, features a key proprietary step that forms the basis of a licence agreement signed recently between SCS and Cambridge Enterprise, the technology transfer company for the University of Cambridge. The licence is a significant addition to SCS' strong portfolio of intellectual property...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...lts, we now look forward to the continued progress of NVA237, and the combination therapy, QVA149." Notes for Editors: About the NVA237 and QVA149 licence agreement with Novartis Sosei and Vectura Group plc concluded a global development and commercialisation agreement with Novartis in April 2005 for t...

New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients

...mon was introduced nearly two decades ago, it has had an established safety and efficacy track record. Studies have confirmed that within its approved licence NeoRecormon has been shown to reduce the need for blood transfusions and to significantly improve quality of life for anaemic patients with cancer bei...

Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet Primary Endpoint

...ogether to fully analyse the full data set for AGI-1067, including these first results. After completion of the final analysis, under the terms of the licence and collaboration agreement AstraZeneca has a 45-day period in which to decide whether or not to continue with the collaboration. -Ends- 19 Marc...

Gardasil Demonstrates Up to 100% Efficacy

...us are very common with the majority of infections occurring in adolescence or early adulthood. , EU indication of Gardasil® According to the licence in the EU, Gardasil®, Human Papillomavirus Vaccine [types 6,11,16,18] (Recombinant, adsorbed), can be given to children and adolescents 9 to15 yea...

Avexa's Apricitabine Clinical Trial Update

...tered into a collaboration with TargetDrug in China to identify new CCR5 inhibitors for the treatment of HIV infections and has an exclusive option to licence TargetDrug's lead CCR5 inhibitor, Nifeviroc. Contact Avexa Dr. Julian Chick, +61 3 9208 4300 Chief Executive Officer licence would be both safe and beneficial to the environment. On July 23 2009 the government inaugurated a public consultation on the release, subject to the ...

Natural seed treatment could drastically cut pesticide use

... the US. Their results showed clear reductions in pest damage with increased crop yields, and has led to the company negotiating a worldwide exclusive licence to use the technology. 'The potential for significant yield improvement due to the lessening of plant damage caused by pests is very exciting,' say...

Queen's receives $9.1 million to establish National Center of Excellence in green chemistry

...ation." Over the next five years GreenCentre Canada aims to manage the commercialization of 50 Green Chemistry technologies, leading to at least 10 licence agreements, and to establish at least six startup companies. During this time, they also anticipate the creation of at least 250 highly skilled jobs. ...

SAFRAN to Acquire Motorola's Biometrics Business

...tratotanker C-17 Globemaster, F/A-18, F-16, F-22, V-22 and C-130. SAFRAN is party to over 100 technical assistance agreements (TAAs) and manufacturing licence agreements (MLAs), has 22 empowered corporate officials dedicated to export control and regulations and is committed to full compliance to such requir...

GKSS membranes reduce air pollution in Beijing

...is a cooperation with the company Eurovapor which delivered about 140 vent processing systems. The membranes developed at the GKSS are manufactured in licence by the company GMT Membrantechnik GmbH in Rheinfelden. ...

Releasing fish for the future

...bream and dusky flathead. The research, costing more than $1.5 million and funded by NSW DPI and the Recreational Fishing Trust (using money from licence fees), is developing protocols designed to maximise fish survival via subtle changes to management practices. Owing to bag limits, legal sizes an...

Breakthrough for stem cell research

...ing this line. We will also make it available to other researchers for their own work." The National Health and Medical Research Council granted a licence to IVF Australia in collaboration with the DTU at the Prince of Wales Hospital to produce six stem cell lines in November 2004. Seed funding for the p...

licence in Biological Technology

GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines

VIENNA, Austria, October 23 /PRNewswire/ -- GlaxoSmithKline Biologicals S.A. (GSK) and AFFiRiS GmbH announced today the execution of a collaboration agreement granting GSK exclusive rights to AFFiRiS's Alzheimer's disease vaccine programmes, aimed at treating Alzheimer's by targeting beta-amyl...

Enigma Diagnostics Announces Patent Licence With Applied Biosystems

PORTON DOWN, England, Oct 22 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it has signed a third licence agreement with Applied Biosystems. The licence provides Enigma with access to claims of US Patent No....

New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA

FRIMLEY, England, September 13 /PRNewswire-FirstCall/ -- - Physicians Welcome New Option for Potentially Life Threatening Disease - Daptomycin has a Rapidly Bactericidal Mode of Action The launch of daptomycin for the treatment of both methicillin-sensitive and resistant Staphylococcus aure...

Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic

...aveformed a partnership to select antibodies against the GPCR. Upon completion of the discovery phase, MSM will grant Debiopharm a worldwide exclusive licence for the development and commercialisation of the antibody. MSM will retain marketing rights for Russia, Ukraine and several other countries in Eastern...

Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency

...uired and where appropriate will build an in-house sales and marketing capability to direct distribution of its products. Enigma has an exclusive licence from the Defence Science and Technology Laboratory to a portfolio of patents, which represent over 15 years of UK Ministry of Defence funded research ...

Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma

...rtment of Pierre Fabre Laboratories, is proud to announce the launch of a set of clinical trials following the signature of an exclusive and worldwide licence agreement on July 10th 2008 with the University of Bordeaux. The contract covers the development, production and marketing of a paediatric beta-blocke...

Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions

...have decided to develop this new therapeutic approach," said Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "This exclusive licence agreement is very exciting and promising: it will speed up the development of a totally new class of painkillers, hence confirming the validity of our...

Photo-catalytic, self cleaning coating for building exteriors

...h the self-cleaning coating. On signing of the licence agreement, Boon Swan Foo, Executive Chairman of Ex...ies, said, "We are delighted to grant the scale-up licence for A*STAR's photo-catalytic coating technology to...ating." Exploit Technologies Pte Ltd signed the licence agreement with Haruna (S) Pte Ltd at the TechLicen...

Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research

...y element of our commercial strategy is to realise both immediate and longer-term value from our extensive IP portfolio in the stem cell field through licence agreements such as this. We are therefore very pleased to have signed this agreement with one of the leading providers of transgenic animal models to ...

Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc.

... Foundation's stem cell initiative. ESGRO Complete(TM) and several other proprietary SCS media products are distributed worldwide under an exclusive licence agreement with Chemicon/Millipore Corporation. About Stem Cell Sciences plc Stem Cell Sciences (SCS) is an international research and development ...

licence in Biological Definition

Down syndrome

...fortable environment for the person with Down syndrome, as they are usually unable to run their own household, apply for a regular job, get a driver's licence and take care of insurances etc. One increasingly popular model in Europe lets four to six people with Down Syndrome share an apartment in a normal re...

licence in Biological Dictionary

Inversion

...et theory. inversion n. The act of inverting . The state of being inverted . ... Inversion of word‐order ( syntax) is a common form of poetic licence allowing a ... Inversion (meteorology) This article needs additional citations for verification. ... An inversion can lead to pollution such as...